Kumar, S. U., Priya, N. M., Nithya, S. R., Kannan, P., Jain, N., Kumar, D. T., . . . Doss, C. G. P. (2021). A review of novel coronavirus disease (COVID-19): Based on genomic structure, phylogeny, current shreds of evidence, candidate vaccines, and drug repurposing. 3 Biotech.
Citação norma ChicagoKumar, S. Udhaya, et al. "A Review of Novel Coronavirus Disease (COVID-19): Based On Genomic Structure, Phylogeny, Current Shreds of Evidence, Candidate Vaccines, and Drug Repurposing." 3 Biotech 2021.
Citação norma MLAKumar, S. Udhaya, et al. "A Review of Novel Coronavirus Disease (COVID-19): Based On Genomic Structure, Phylogeny, Current Shreds of Evidence, Candidate Vaccines, and Drug Repurposing." 3 Biotech 2021.
Nota: a formatação da citação pode não corresponder 100% ao definido pela respectiva norma.